Skip to main content
Erschienen in: Inflammation 4/2012

01.08.2012

Peripheral Blood Neutrophil Activity During Dermatophagoides pteronyssinus-Induced Late-Phase Airway Inflammation in Patients with Allergic Rhinitis and Asthma

verfasst von: Simona Lavinskiene, Jolanta Jeroch, Kestutis Malakaskas, Ieva Bajoriuniene, Jurgita Jackute, Raimundas Sakalauskas

Erschienen in: Inflammation | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Recent investigations suggest that neutrophils may play an important role in the late-phase allergen-induced inflammation in allergic airway diseases. The aim of this study was to evaluate neutrophil chemotaxis, phagocytic activity, and reactive oxygen species (ROS) production in patients with allergic rhinitis and asthma challenged with inhaled Dermatophagoides pteronyssinus. Eighteen patients with allergic rhinitis and 14 with allergic asthma, all sensitized to D. pteronyssinus, as well as 15 healthy individuals underwent bronchial challenge with D. pteronyssinus. Peripheral blood collection and neutrophil isolation were performed 24 h before as well as 7 and 24 h after bronchial challenge. Neutrophils chemotaxis, phagocytic activity, and ROS production were analyzed by flow cytometer. Neutrophil chemotaxis and ROS production were increased, while phagocytic activity was decreased 24 h before challenge in patient groups compared with healthy individuals. After challenge, neutrophil chemotaxis and phagocytic activity increased after 7 and 24 h, when ROS production, only after 24 h. Bronchial allergen challenge had no influence for neutrophils activity in healthy subjects. Activated chemotaxis, phagocytic activity, and ROS production of peripheral blood neutrophils after challenge with D. pteronyssinus reflect an enhanced systemic inflammation in allergic rhinitis and asthma patients with induced late-phase airway inflammation.
Literatur
1.
Zurück zum Zitat Barnes, P.J. 2011. Pathophysiology of allergic inflammation. Immunology Review 242: 31–50.CrossRef Barnes, P.J. 2011. Pathophysiology of allergic inflammation. Immunology Review 242: 31–50.CrossRef
2.
Zurück zum Zitat Nakagome, K., and M. Nagata. 2011. Pathogenesis of airway inflammation in bronchial asthma. Auris, Nasus, Larynx 38: 555–563.PubMedCrossRef Nakagome, K., and M. Nagata. 2011. Pathogenesis of airway inflammation in bronchial asthma. Auris, Nasus, Larynx 38: 555–563.PubMedCrossRef
3.
Zurück zum Zitat Monteseirin, J. 2009. Neutrophils and asthma. Journal of Investigational Allergology and Clinical Immunology 19: 340–354.PubMed Monteseirin, J. 2009. Neutrophils and asthma. Journal of Investigational Allergology and Clinical Immunology 19: 340–354.PubMed
4.
Zurück zum Zitat Foley, S.C., and Q. Hamid. 2007. Images in allergy and immunology. The Journal of Allergy and Clinical Immunology 119: 1282–1286.PubMedCrossRef Foley, S.C., and Q. Hamid. 2007. Images in allergy and immunology. The Journal of Allergy and Clinical Immunology 119: 1282–1286.PubMedCrossRef
5.
Zurück zum Zitat Strieter, R.M., K. Kasahara, R.M. Allen, et al. 1992. Cytokine-induced neutrophil-derived interleukin-8. American Journal of Pathology 141: 397–407.PubMed Strieter, R.M., K. Kasahara, R.M. Allen, et al. 1992. Cytokine-induced neutrophil-derived interleukin-8. American Journal of Pathology 141: 397–407.PubMed
6.
Zurück zum Zitat Beeh, K.M., O. Kornmann, R. Buhl, S.V. Culpitt, et al. 2003. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123: 1240–1247.PubMedCrossRef Beeh, K.M., O. Kornmann, R. Buhl, S.V. Culpitt, et al. 2003. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123: 1240–1247.PubMedCrossRef
7.
Zurück zum Zitat Yao, H., and I. Rahman. 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology 254: 72–85.PubMedCrossRef Yao, H., and I. Rahman. 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology 254: 72–85.PubMedCrossRef
8.
Zurück zum Zitat Stringer, K.A., M. Tobias, H.C. O’Neill, et al. 2007. Cigarette smoke extract-induced suppression of caspase-3-like activity impairs human neutrophil phagocytosis. American Journal of Physiology. Lung Cellular and Molecular Physiology 292: L1572–L1579.PubMedCrossRef Stringer, K.A., M. Tobias, H.C. O’Neill, et al. 2007. Cigarette smoke extract-induced suppression of caspase-3-like activity impairs human neutrophil phagocytosis. American Journal of Physiology. Lung Cellular and Molecular Physiology 292: L1572–L1579.PubMedCrossRef
9.
Zurück zum Zitat Baginski, T.K., K. Dabbagh, C. Satiawatcharaphong, et al. 2006. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. American Journal of Respiratory Cell and Molecular Biology 35: 165–174.PubMedCrossRef Baginski, T.K., K. Dabbagh, C. Satiawatcharaphong, et al. 2006. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. American Journal of Respiratory Cell and Molecular Biology 35: 165–174.PubMedCrossRef
10.
Zurück zum Zitat Drews, A.C., M.M. Pizzichini, E. Pizzichini, et al. 2009. Neutrophilic inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy 64: 1597–1601.PubMedCrossRef Drews, A.C., M.M. Pizzichini, E. Pizzichini, et al. 2009. Neutrophilic inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy 64: 1597–1601.PubMedCrossRef
11.
Zurück zum Zitat Kämpe, M., I. Stolt, M. Lampinen, et al. 2011. Patients with allergic rhinitis and allergic asthma share the same pattern of eosinophil and neutrophil degranulation after allergen challenge. Clinical and Molecular Allergy 9: 3.PubMedCrossRef Kämpe, M., I. Stolt, M. Lampinen, et al. 2011. Patients with allergic rhinitis and allergic asthma share the same pattern of eosinophil and neutrophil degranulation after allergen challenge. Clinical and Molecular Allergy 9: 3.PubMedCrossRef
12.
Zurück zum Zitat Lommatzsch, M., P. Julius, M. Kuepper, et al. 2006. The course of allergen-induced leukocyte infiltration in human and experimental asthma. The Journal of Allergy and Clinical Immunology 118: 91–97.PubMedCrossRef Lommatzsch, M., P. Julius, M. Kuepper, et al. 2006. The course of allergen-induced leukocyte infiltration in human and experimental asthma. The Journal of Allergy and Clinical Immunology 118: 91–97.PubMedCrossRef
13.
Zurück zum Zitat Monteseirín, J., M.J. Camacho, I. Bonilla, et al. 2002. Respiratory burst in neutrophils from asthmatic patients. The Journal of Asthma 39: 619–624.PubMedCrossRef Monteseirín, J., M.J. Camacho, I. Bonilla, et al. 2002. Respiratory burst in neutrophils from asthmatic patients. The Journal of Asthma 39: 619–624.PubMedCrossRef
14.
Zurück zum Zitat Henricks, P.A., and F.P. Nijkamp. 2001. Reactive oxygen species as mediators in asthma. Pulmonary Pharmacology & Therapeutics 14: 409–420.CrossRef Henricks, P.A., and F.P. Nijkamp. 2001. Reactive oxygen species as mediators in asthma. Pulmonary Pharmacology & Therapeutics 14: 409–420.CrossRef
15.
Zurück zum Zitat Hatzivlassiou, M., C. Grainge, V. Kehagia, et al. 2010. The allergen specificity of the late asthmatic reaction. Allergy 65: 355–358.PubMedCrossRef Hatzivlassiou, M., C. Grainge, V. Kehagia, et al. 2010. The allergen specificity of the late asthmatic reaction. Allergy 65: 355–358.PubMedCrossRef
16.
Zurück zum Zitat Bousquet, J., N. Khaltaev, A.A. Cruz, et al. 2008. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the WHO, GA2LEN and AllerGen). Allergy 63: 8–160.PubMedCrossRef Bousquet, J., N. Khaltaev, A.A. Cruz, et al. 2008. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the WHO, GA2LEN and AllerGen). Allergy 63: 8–160.PubMedCrossRef
17.
Zurück zum Zitat Global Initiative for Asthma. Global strategy for asthma management and prevention. 2010. NHLBI/WHO workshop. Bethesda: National Institutes of Health. http://www.ginasthma.com. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2010. NHLBI/WHO workshop. Bethesda: National Institutes of Health. http://​www.​ginasthma.​com.
18.
Zurück zum Zitat Dreborg, S., A. Backman, and A. Basoma. 1989. Skin tests used in type I allergy testing. Position paper. Allergy 10: 1–59. Dreborg, S., A. Backman, and A. Basoma. 1989. Skin tests used in type I allergy testing. Position paper. Allergy 10: 1–59.
19.
Zurück zum Zitat Miller, M.R., J. Hankinson, V. Brusasco, et al. 2005. ATS/ERS Task force standardisation of lung function testing. Standardisation of spirometry. European Respiratory Journal 26: 319–338.PubMedCrossRef Miller, M.R., J. Hankinson, V. Brusasco, et al. 2005. ATS/ERS Task force standardisation of lung function testing. Standardisation of spirometry. European Respiratory Journal 26: 319–338.PubMedCrossRef
20.
Zurück zum Zitat Baur, X., H. Huber, P.O. Degens, et al. 1998. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. American Journal of Industrial Medicine 33: 114–122.PubMedCrossRef Baur, X., H. Huber, P.O. Degens, et al. 1998. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. American Journal of Industrial Medicine 33: 114–122.PubMedCrossRef
21.
Zurück zum Zitat Liu, L., N.N. Jarjour, W.W. Busse, et al. 2004. Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. American Journal of Respiratory and Critical Care Medicine 169: 1118–1124.PubMedCrossRef Liu, L., N.N. Jarjour, W.W. Busse, et al. 2004. Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. American Journal of Respiratory and Critical Care Medicine 169: 1118–1124.PubMedCrossRef
22.
Zurück zum Zitat Erger, R.A., and T.B. Casale. 1998. Interleukin-8 plays a significant role in IgE-mediated lung inflammation. European Respiratory Journal 11: 299–305.PubMedCrossRef Erger, R.A., and T.B. Casale. 1998. Interleukin-8 plays a significant role in IgE-mediated lung inflammation. European Respiratory Journal 11: 299–305.PubMedCrossRef
23.
Zurück zum Zitat Panina-Bordignon, P., and D. D’Ambrosio. 2003. Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 9: 104–110.PubMedCrossRef Panina-Bordignon, P., and D. D’Ambrosio. 2003. Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 9: 104–110.PubMedCrossRef
24.
Zurück zum Zitat Terada, L.S. 2006. Specificity in reactive oxidant signalling: think globally, act locally. The Journal of Cell Biology 174: 615–623.PubMedCrossRef Terada, L.S. 2006. Specificity in reactive oxidant signalling: think globally, act locally. The Journal of Cell Biology 174: 615–623.PubMedCrossRef
25.
Zurück zum Zitat Walter, R.E., J.B. Wilk, M.G. Larson, et al. 2008. Systemic inflammation and COPD. The Framingham Heart Study. Chest 133: 19–25.PubMedCrossRef Walter, R.E., J.B. Wilk, M.G. Larson, et al. 2008. Systemic inflammation and COPD. The Framingham Heart Study. Chest 133: 19–25.PubMedCrossRef
26.
Zurück zum Zitat Babior, B.M., J.D. Lambeth, and W. Nauseef. 2002. The neutrophil NADPH oxidase. Archives of Biochemistry and Biophysics 397: 342–324.PubMedCrossRef Babior, B.M., J.D. Lambeth, and W. Nauseef. 2002. The neutrophil NADPH oxidase. Archives of Biochemistry and Biophysics 397: 342–324.PubMedCrossRef
27.
Zurück zum Zitat Galli, S.J., M. Tsai, and A.M. Piliponsky. 2008. The development of allergic inflammation. Nature 454: 445–454.PubMedCrossRef Galli, S.J., M. Tsai, and A.M. Piliponsky. 2008. The development of allergic inflammation. Nature 454: 445–454.PubMedCrossRef
28.
Zurück zum Zitat Dahlgren, C., A. Karlsson, and J. Bylund. 2007. Measurement of respiratory burst products generated by professional phagocytes. Methods in Molecular Biology 412: 349–363.PubMedCrossRef Dahlgren, C., A. Karlsson, and J. Bylund. 2007. Measurement of respiratory burst products generated by professional phagocytes. Methods in Molecular Biology 412: 349–363.PubMedCrossRef
29.
Zurück zum Zitat Serrander, L., V. Jaquet, K. Bedard, et al. 2007. NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. Biochimie 89: 1159–1167.PubMedCrossRef Serrander, L., V. Jaquet, K. Bedard, et al. 2007. NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. Biochimie 89: 1159–1167.PubMedCrossRef
30.
Zurück zum Zitat Boldogh, I., A. Bacsi, and B.K. Choudhury. 2005. ROS generated by pollen NADPH oxidase provide a signal that augments antigen induced allergic airway inflammation. Journal of Clinical Investigation 115: 2169–2179.PubMedCrossRef Boldogh, I., A. Bacsi, and B.K. Choudhury. 2005. ROS generated by pollen NADPH oxidase provide a signal that augments antigen induced allergic airway inflammation. Journal of Clinical Investigation 115: 2169–2179.PubMedCrossRef
31.
Zurück zum Zitat Blüml, S., B. Rosc, A. Lorincz, et al. 2008. The oxidation state of phospholipids controls the oxidative burst in neutrophil granulocytes. Journal of Immunology 181: 4347–4353. Blüml, S., B. Rosc, A. Lorincz, et al. 2008. The oxidation state of phospholipids controls the oxidative burst in neutrophil granulocytes. Journal of Immunology 181: 4347–4353.
32.
Zurück zum Zitat Murdoch, J.R., and C.M. Lloyd. 2010. Chronic inflammation and asthma. Mutation Research 690: 24–39.PubMedCrossRef Murdoch, J.R., and C.M. Lloyd. 2010. Chronic inflammation and asthma. Mutation Research 690: 24–39.PubMedCrossRef
33.
Zurück zum Zitat van der Vliet, A. 2008. NADPH oxidases in lung biology and pathology. Host defense enzymes, and more. Free Radical Biology & Medicine 44: 938–955.CrossRef van der Vliet, A. 2008. NADPH oxidases in lung biology and pathology. Host defense enzymes, and more. Free Radical Biology & Medicine 44: 938–955.CrossRef
34.
Zurück zum Zitat Wood, L.G., P.G. Gibson, and M.L. Garg. 2003. Biomarkers of lipid peroxidation, airway inflammation and asthma. European Respiratory Journal 21: 177–186.PubMedCrossRef Wood, L.G., P.G. Gibson, and M.L. Garg. 2003. Biomarkers of lipid peroxidation, airway inflammation and asthma. European Respiratory Journal 21: 177–186.PubMedCrossRef
Metadaten
Titel
Peripheral Blood Neutrophil Activity During Dermatophagoides pteronyssinus-Induced Late-Phase Airway Inflammation in Patients with Allergic Rhinitis and Asthma
verfasst von
Simona Lavinskiene
Jolanta Jeroch
Kestutis Malakaskas
Ieva Bajoriuniene
Jurgita Jackute
Raimundas Sakalauskas
Publikationsdatum
01.08.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9475-0

Weitere Artikel der Ausgabe 4/2012

Inflammation 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.